Unbiased estimation for response adaptive clinical trials

被引:27
作者
Bowden, Jack [1 ,2 ]
Trippa, Lorenzo [3 ]
机构
[1] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England
[2] MRC Biostat Unit, Cambridge, England
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
Clinical trial; adaptive randomization; bias adjusted estimation; Horvitz-Thompson estimator; inverse probability weighting; Rao-Blackwellization; PROGRESSION-FREE SURVIVAL; RANDOMIZATION; DESIGNS;
D O I
10.1177/0962280215597716
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Bayesian adaptive trials have the defining feature that the probability of randomization to a particular treatment arm can change as information becomes available as to its true worth. However, there is still a general reluctance to implement such designs in many clinical settings. One area of concern is that their frequentist operating characteristics are poor or, at least, poorly understood. We investigate the bias induced in the maximum likelihood estimate of a response probability parameter, p, for binary outcome by the process of adaptive randomization. We discover that it is small in magnitude and, under mild assumptions, can only be negative - causing one's estimate to be closer to zero on average than the truth. A simple unbiased estimator for p is obtained, but it is shown to have a large mean squared error. Two approaches are therefore explored to improve its precision based on inverse probability weighting and Rao-Blackwellization. We illustrate these estimation strategies using two well-known designs from the literature.
引用
收藏
页码:2376 / 2388
页数:13
相关论文
共 37 条
[1]   Progression-free survival: too much risk, not enough reward? [J].
Alexander, Brian M. ;
Trippa, Lorenzo .
NEURO-ONCOLOGY, 2014, 16 (05) :615-616
[2]   Biomarker-based adaptive trials for patients With glioblastoma-lessons from I-SPY 2 [J].
Alexander, Brian M. ;
Wen, Patrick Y. ;
Trippa, Lorenzo ;
Reardon, David A. ;
Yung, Wai-Kwan Alfred ;
Parmigiani, Giovanni ;
Berry, Donald A. .
NEURO-ONCOLOGY, 2013, 15 (08) :972-978
[3]  
[Anonymous], 1999, GROUP SEQUENTIAL MET
[4]   I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy [J].
Barker, A. D. ;
Sigman, C. C. ;
Kelloff, G. J. ;
Hylton, N. M. ;
Berry, D. A. ;
Esserman, L. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (01) :97-100
[5]   EVALUATION OF EXPERIMENTS WITH ADAPTIVE INTERIM ANALYSES [J].
BAUER, P ;
KOHNE, K .
BIOMETRICS, 1994, 50 (04) :1029-1041
[6]   Selection and bias-Two hostile brothers [J].
Bauer, Peter ;
Koenig, Franz ;
Brannath, Werner ;
Posch, Martin .
STATISTICS IN MEDICINE, 2010, 29 (01) :1-13
[7]   ADAPTIVE ASSIGNMENT VERSUS BALANCED RANDOMIZATION IN CLINICAL-TRIALS - A DECISION-ANALYSIS [J].
BERRY, DA ;
EICK, SG .
STATISTICS IN MEDICINE, 1995, 14 (03) :231-246
[8]   Adaptive Clinical Trials: The Promise and the Caution [J].
Berry, Donald A. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (06) :606-609
[9]  
Boos D. D., 2013, ESSENTIAL STAT INFER
[10]   A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials [J].
Bowden, J. ;
Mander, A. .
PHARMACEUTICAL STATISTICS, 2014, 13 (03) :163-172